Clear Search sequence regions


  • blood (5)
  • cholesterol (4)
  • curcumin (8)
  • factor (2)
  • improves (1)
  • insulin (6)
  • leptin (4)
  • lipid (1)
  • liver (1)
  • male (2)
  • mass (2)
  • NF κB (5)
  • period (1)
  • rats (7)
  • serum (3)
  • TNF α (6)
  • tumor necrosis factor (2)
  • uric acid (4)
  • weight (1)
  • Sizes of these terms reflect their relevance to your search.

    This study aimed to investigate effects of curcumin on high fructose diet (HFD)-induced metabolic syndrome (MetS) in rats and the possible mechanisms involved. MetS was induced in male albino rats (n = 20), over 8 weeks, by 65% HFD. For 8-week experiment period, rats were assigned to 2 equal groups: curcumin-treated rats received curcumin (200 mg/kg, p.o, once daily) along with HFD, and untreated rats were fed with HFD only. We evaluated body mass (BM), systolic blood pressure (SBP), homeostasis model assessment of insulin resistance (HOMA-IR), and serum levels of glucose, insulin, leptin, total cholesterol (TC), triglycerides (TGs), uric acid, malondialdehyde (MDA; lipid peroxidation product), and tumor necrosis factor-α (TNF-α; inflammatory cytokine), and serum catalase (endogenous antioxidant) activity and immunohistochemical expression of nuclear factor κB (NF-κB; inflammation-related transcription factor) in hepatocytes. HFD produced increases in BM, SBP, HOMA-IR, and serum levels of glucose, insulin, leptin, TC, TGs, uric acid, MDA, and TNF-α, a decrease in catalase activity, and strong positive expression of NF-κB in hepatocytes. Curcumin, in presence of HFD, produced significant improvements in all glucose and fat metabolism parameters, and in oxidative stress and inflammation biomarkers. Curcumin may potentially be useful in the treatment of MetS through its ability to modulate oxidation stress status and inflammation cascades.

    Citation

    Mohamed Elsayed Kelany, Tahir M Hakami, Adel H Omar. Curcumin improves the metabolic syndrome in high-fructose-diet-fed rats: role of TNF-α, NF-κB, and oxidative stress. Canadian journal of physiology and pharmacology. 2017 Feb;95(2):140-150

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 27901349

    View Full Text